TD Cowen Keeps Their Buy Rating on R1 RCM (RCM)

TipRanks19:49

Truist Financial Gives a Hold Rating to R1 RCM (RCM)

TipRanks19:19

Buy Rating Affirmed for Simulations Plus Amidst Strong Growth and Strategic Acquisitions

TipRanksJul 4 21:20

Analysts Offer Insights on Healthcare Companies: R1 RCM (RCM), Legend Biotech (LEGN) and Intuitive Surgical (ISRG)

TipRanksJul 4 15:14

Buy Rating on R1 RCM Amid Acquisition Interest and Market Undervaluation

TipRanksJul 4 13:37

Craig-Hallum Reiterates Buy on Simulations Plus, Maintains $56 Price Target

BenzingaJul 4 01:39

HealthEquity Analyst Ratings

BenzingaJul 3 21:15

B of A Securities Maintains Buy on HealthEquity, Maintains $105 Price Target

BenzingaJul 3 21:15

Buy Rating Affirmed for R1 RCM on Market Leadership and AI Growth Prospects

TipRanksJul 3 18:29

Maintaining Buy Rating on Healthequity Amid Limited Impact Security Incident

TipRanksJul 3 18:22

Barclays Starts Waystar Holding With Overweight Rating, $24 Price Target

MT NewswiresJul 3 17:37

Waystar Holding Corp. (WAY) Receives a New Rating From Barclays

TipRanksJul 3 16:27

BofA, J.P. Morgan Start Coverage of Waystar With Bullish Ratings

Seeking AlphaJul 3 03:27

Schrodinger Analyst Ratings

BenzingaJul 3 01:02

Leerink Partners Initiates Coverage On Schrodinger With Outperform Rating, Announces Price Target of $29

BenzingaJul 3 01:02

RBC Capital Initiates Coverage On Waystar Holding With Outperform Rating, Announces Price Target of $27

BenzingaJul 3 00:08

R1 RCM Analyst Ratings

BenzingaJul 2 23:18

Cantor Fitzgerald Reiterates Overweight on R1 RCM, Maintains $20 Price Target

BenzingaJul 2 23:18

Assessing R1 RCM's Value Amidst Transaction Uncertainty and Client Challenges: A 'Buy' Rating Justification

TipRanksJul 2 21:27

Evercore ISI Remains a Hold on R1 RCM (RCM)

TipRanksJul 2 19:59